| A copeptin-based approach in the diagnosis of diabetes insipidus W Fenske, J Refardt, I Chifu, I Schnyder, B Winzeler, J Drummond, ... New England Journal of Medicine 379 (5), 428-439, 2018 | 247 | 2018 |
| Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial TR Pieber, B Bode, A Mertens, YM Cho, E Christiansen, CL Hertz, ... The lancet Diabetes & endocrinology 7 (7), 528-539, 2019 | 221 | 2019 |
| Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study E Christ, D Wild, S Ederer, M Béhé, G Nicolas, ME Caplin, M Brändle, ... The lancet Diabetes & endocrinology 1 (2), 115-122, 2013 | 187 | 2013 |
| Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL) R Trepp, R Everts, C Stettler, S Fischli, S Allemann, SM Webb, ER Christ Clinical endocrinology 63 (1), 103-110, 2005 | 116 | 2005 |
| Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma T Zueger, P Kirchner, C Herren, S Fischli, M Zwahlen, E Christ, C Stettler The Journal of Clinical Endocrinology & Metabolism 97 (10), E1938-E1942, 2012 | 102 | 2012 |
| Dehydroepiandrosterone sulfate in the assessment of the hypothalamic-pituitary-adrenal axis S Fischli, S Jenni, S Allemann, M Zwahlen, P Diem, ER Christ, C Stettler The Journal of Clinical Endocrinology & Metabolism 93 (2), 539-542, 2008 | 66 | 2008 |
| External validation of the GREAT score to predict relapse risk in Graves' disease: results from a multicenter, retrospective study with 741 patients T Struja, M Kaeslin, F Boesiger, R Jutzi, N Imahorn, A Kutz, L Bernasconi, ... European journal of endocrinology 176 (4), 413-419, 2017 | 64 | 2017 |
| The significance of 18F-fluorocholine-PET/CT as localizing imaging technique in patients with primary hyperparathyroidism and negative conventional imaging S Fischli, I Suter-Widmer, BT Nguyen, W Müller, J Metzger, K Strobel, ... Frontiers in Endocrinology 8, 380, 2018 | 38 | 2018 |
| Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites? E Grouzmann, O Tschopp, F Triponez, M Matter, S Bilz, M Brändle, ... PLoS One 10 (5), e0125426, 2015 | 38 | 2015 |
| Is Graves’ disease a primary immunodeficiency? New immunological perspectives on an endocrine disease T Struja, A Kutz, S Fischli, C Meier, B Mueller, M Recher, P Schuetz BMC medicine 15, 1-15, 2017 | 35 | 2017 |
| Endokrinologie und Stoffwechsel GA Spinas, S Fischli, K Berneis, S Fischli Thieme, 2011 | 32 | 2011 |
| Rapid preoperative blockage of thyroid hormone production/secretion in patients with Graves’ disease S Fischli, B Lucchini, W Müller, L Slahor, C Henzen Swiss medical weekly 146 (0102), w14243-w14243, 2016 | 26 | 2016 |
| Risk of perioperative thyroid storm in hyperthyroid patients: a systematic review N de Mul, J Damstra, EJMN van Dijkum, S Fischli, CJ Kalkman, ... British Journal of Anaesthesia 127 (6), 879-889, 2021 | 20 | 2021 |
| Long-term effects of initiating continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) in people with type 1 diabetes and unsatisfactory … JD Senn, S Fischli, L Slahor, S Schelbert, C Henzen Journal of clinical medicine 8 (3), 394, 2019 | 20 | 2019 |
| Iron metabolism in patients with Graves’ hyperthyroidism S Fischli, V von Wyl, M Trummler, D Konrad, S Wueest, A Ruefer, ... Clinical endocrinology 87 (5), 609-616, 2017 | 18 | 2017 |
| Endocrinologic side effects of oncologic treatment with anti-CTLA-4-antibodies S Fischli, S Allelein, T Zander, C Henzen Deutsche medizinische Wochenschrift (1946) 139 (19), 996-1000, 2014 | 14 | 2014 |
| Hypomagnesemia-induced cerebellar syndrome—a distinct disease entity? Case report and literature review CP Kamm, T Nyffeler, C Henzen, S Fischli Frontiers in neurology 11, 968, 2020 | 13 | 2020 |
| Localisation of ectopic mediastinal parathyroid adenoma by 18F-fluorocholine PET/CT M Triantafyllidou, K Strobel, A Leiser, S Fischli Case Reports 2018, bcr-2017-222089, 2018 | 12 | 2018 |
| 18F-Fluorocholine-PET combined with contrast-enhanced CT for localizing hyperfunctioning parathyroid glands and optimizing surgical treatment in patients with … JM Gass, C Wicke, C Mona, K Strobel, W Müller, J Metzger, ... Endocrine, 1-8, 2022 | 11 | 2022 |
| Canakinumab in patients with COVID-19 and type 2 diabetes–A multicentre, randomised, double-blind, placebo-controlled trial M Hepprich, JM Mudry, C Gregoriano, FR Jornayvaz, S Carballo, ... EClinicalMedicine 53, 2022 | 9 | 2022 |
